Uteron Pharma S.A.

Quick facts

Phase 3 pipeline

• Levosert-20 · Contraception / Gynecology
  Levosert-20 is a levonorgestrel-releasing intrauterine system designed to provide long-acting contraception and reduce menstrual bleeding.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Uteron Pharma S.A. portfolio CI brief
• Uteron Pharma S.A. pipeline updates RSS